Raymond James Trust’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,046
Closed -$655K 1177
2021
Q4
$655K Hold
4,046
0.02% 553
2021
Q3
$672K Buy
4,046
+445
+12% +$76K 0.02% 516
2021
Q2
$622K Sell
3,601
-105
-3% -$17.3K 0.02% 537
2021
Q1
$595K Sell
3,706
-695
-16% -$119K 0.02% 524
2020
Q4
$739K Sell
4,401
-188
-4% -$30.5K 0.03% 418
2020
Q3
$722K Sell
4,589
-5
-0.1% -$817 0.03% 388
2020
Q2
$771K Buy
4,594
+119
+3% +$18.7K 0.04% 356
2020
Q1
$587K Sell
4,475
-858
-16% -$122K 0.03% 370
2019
Q4
$793K Sell
5,333
-232
-4% -$31.9K 0.04% 356
2019
Q3
$689K Sell
5,565
-495
-8% -$65.9K 0.04% 375
2019
Q2
$854K Sell
6,060
-182
-3% -$25.1K 0.05% 318
2019
Q1
$942K Buy
6,242
+498
+9% +$71.7K 0.05% 285
2018
Q4
$713K Buy
5,744
+68
+1% +$9.3K 0.05% 314
2018
Q3
$899K Hold
5,676
0.05% 297
2018
Q2
$795K Sell
5,676
-615
-10% -$84.4K 0.05% 307
2018
Q1
$836K Sell
6,291
-195
-3% -$26.6K 0.06% 268
2017
Q4
$808K Buy
6,486
+943
+17% +$117K 0.05% 286
2017
Q3
$687K Buy
5,543
+195
+4% +$23.1K 0.05% 303
2017
Q2
$610K Hold
5,348
0.05% 323
2017
Q1
$564K Hold
5,348
0.04% 334
2016
Q4
$486K Sell
5,348
-1,200
-18% -$112K 0.04% 360
2016
Q3
$653K Buy
6,548
+1,000
+18% +$98.1K 0.06% 289
2016
Q2
$496K Buy
5,548
+1,225
+28% +$113K 0.04% 332
2016
Q1
$379K Sell
4,323
-590
-12% -$52K 0.04% 392
2015
Q4
$555K Buy
4,913
+2,295
+88% +$247K 0.05% 315
2015
Q3
$266K Buy
2,618
+854
+48% +$102K 0.03% 452
2015
Q2
$219K Buy
+1,764
New +$213K 0.02% 550

Other funds holding FBT

Raymond James Trust's FBT Position: Q1 2022 in Review

Raymond James Trust sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2022, closing a stake of 4,046 shares — an estimated $655K sold.

Raymond James Trust first reported a position in FBT in Q2 2015 and held it in 27 quarters. The position peaked at $942K in Q1 2019. 220 funds tracked by Wall St. Rank hold FBT as of Q1 2022.

  • Raymond James Trust reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2022 after selling out during the quarter.
  • Raymond James Trust sold 4,046 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2022, an estimated $655K.
  • Raymond James Trust first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2015 and held it in 27 quarters.
  • Raymond James Trust's First Trust NYSE Arca Biotechnology Index Fund position peaked at $942K in Q1 2019.
  • 220 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2022.

Based on Raymond James Trust's 13F filing for Q1 2022, filed 12 May 2022.